Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16-week multicentre retrospective study.
Gargiulo L, Ibba L, Piscazzi F, Amoruso F, Balato A, Barei F, Bertello M, Burroni AG, Caccavale S, Ferrucci SM, Foti C, Gaiani FM, Girolomoni G, Malagoli P, Marzano AV, Maurelli M, Napolitano M, Nettis E, Ortoncelli M, Patruno C, Pezzolo E, Ribero S, Romita P, Rossi MT, Zaza I, Guanti MB, Costanzo A, Narcisi A. Gargiulo L, et al. Among authors: malagoli p. J Eur Acad Dermatol Venereol. 2024 Sep;38(9):e743-e746. doi: 10.1111/jdv.19862. Epub 2024 Feb 8. J Eur Acad Dermatol Venereol. 2024. PMID: 38329235 No abstract available.
Semaglutide therapy decreases epicardial fat inflammation and improves psoriasis severity in patients affected by abdominal obesity and type-2 diabetes.
Malavazos AE, Meregalli C, Sorrentino F, Vignati A, Dubini C, Scravaglieri V, Basilico S, Boniardi F, Spagnolo P, Malagoli P, Romanelli P, Secchi F, Iacobellis G. Malavazos AE, et al. Among authors: malagoli p. Endocrinol Diabetes Metab Case Rep. 2023 Aug 8;2023(3):23-0017. doi: 10.1530/EDM-23-0017. Endocrinol Diabetes Metab Case Rep. 2023. PMID: 37551923 Free PMC article.
Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience.
Gargiulo L, Ibba L, Vignoli CA, Ferrucci SM, Mercuri SR, Malagoli P, Marzano AV, Barbareschi M, Bianchi VG, Valenti M, Costanzo A, Narcisi A. Gargiulo L, et al. Among authors: malagoli p. J Dermatolog Treat. 2023 Dec;34(1):2268764. doi: 10.1080/09546634.2023.2268764. Epub 2023 Oct 11. J Dermatolog Treat. 2023. PMID: 37818648 Free article. No abstract available.
Safety profile of risankizumab in the treatment of psoriasis patients with concomitant hepatitis B or C infection: A multicentric retrospective cohort study of 49 patients.
Ciolfi C, Balestri R, Bardazzi F, Burlando M, Chersi K, Costanzo A, Dapavo P, Gisondi P, Malagoli P, Pizzolato M, Rech G, Russo FP, Battistella S, Piaserico S. Ciolfi C, et al. Among authors: malagoli p. J Eur Acad Dermatol Venereol. 2023 Oct;37(10):e1203-e1207. doi: 10.1111/jdv.19186. Epub 2023 May 18. J Eur Acad Dermatol Venereol. 2023. PMID: 37170951 No abstract available.
Real-life experience with ixekizumab in plaque psoriasis: a multi-center, retrospective, 3-year study.
Caldarola G, Chiricozzi A, Megna M, Dapavo P, Giunta A, Burlando M, Malagoli P, Dini V, Mariani M, Fabbrocini G, Quaglino P, Bianchi L, Parodi A, Peris K, De Simone C. Caldarola G, et al. Among authors: malagoli p. Expert Opin Biol Ther. 2023 Apr;23(4):365-370. doi: 10.1080/14712598.2023.2193288. Epub 2023 Mar 20. Expert Opin Biol Ther. 2023. PMID: 36927246
111 results